NCT01938326 is a NA clinical trial of Approach Method in Early Gastric Cancer, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT01938326?

NCT01938326 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT01938326?

Interventions in NCT01938326: Approach Method.

What condition does NCT01938326 study?

NCT01938326 studies Early Gastric Cancer.

Is NCT01938326 still recruiting?

NCT01938326 is currently completed. Last updated 6 September 2022.

Last reviewed 2022-09-06 · How we verify

NCT01938326

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) Versus Totally Laparoscopic Distal Gastrectomy (TLDG)

Completed NA Last updated 6 September 2022

What this trial tests

NA trial testing Approach Method in Early Gastric Cancer in 86 participants. Completed in 30 April 2020.

Timeline

1 September 2017

Primary endpoint
27 February 2020

30 April 2020

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	86
Start date	1 September 2017
Primary completion	27 February 2020
Estimated completion	30 April 2020
Sites	1 location across South Korea

Drugs / interventions tested

Approach Method

Conditions studied

Early Gastric Cancer — all drugs for Early Gastric Cancer →

Sponsor

Seoul National University Bundang Hospital

Who can join

Adults 20 to 80, any sex, with Early Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Compare the immune response and postoperative complications between pure SIDG (single-incision laparoscopic distal gastrectomy) and TLDG (totally laparoscopic distal gastrectomy) for early gastric cancer (EGC) 2. Validate the safety, usefulness, minimal invasiveness and feasibility of SIDG (EGC)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Postoperative pain and quality of life after single-incision distal gastrectomy versus multiport laparoscopic distal gastrectomy for early gastric cancer - a randomized controlled trial.
Kang SH, Yoo M, Hwang D, Lee E, et al · · 2023 · cited 9× · PMID 36307602 · DOI 10.1007/s00464-022-09709-6
How much progress has been made in minimally invasive surgery for gastric cancer in Korea?: a viewpoint from Korean prospective clinical trials.
Kim KH, Kim SH, Kim MC. · · 2014 · cited 4× · PMID 25526443 · DOI 10.1097/md.0000000000000233

Verify or expand the search:

Other recruiting trials for Early Gastric Cancer

Currently open trials in the same condition.

NCT07253948 — Distribution Characteristics of Helicobacter Pylori · recruiting
NCT06962293 — Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection · NA · recruiting
NCT06748352 — Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer · NA · recruiting
NCT06788548 — Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastri · NA · recruiting
NCT05323929 — The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma · NA · recruiting

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01938326 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 6 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01938326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing